US1870107A - Medicated ointment composition - Google Patents
Medicated ointment composition Download PDFInfo
- Publication number
- US1870107A US1870107A US430446A US43044630A US1870107A US 1870107 A US1870107 A US 1870107A US 430446 A US430446 A US 430446A US 43044630 A US43044630 A US 43044630A US 1870107 A US1870107 A US 1870107A
- Authority
- US
- United States
- Prior art keywords
- ointment
- phenylphenol
- composition
- water
- ointment composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title description 50
- 239000002674 ointment Substances 0.000 title description 47
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 44
- 239000003814 drug Substances 0.000 description 20
- 239000003883 ointment base Substances 0.000 description 11
- 239000004306 orthophenyl phenol Substances 0.000 description 11
- 235000010292 orthophenyl phenol Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000019271 petrolatum Nutrition 0.000 description 8
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 239000004264 Petrolatum Substances 0.000 description 6
- 229940066842 petrolatum Drugs 0.000 description 6
- 230000002070 germicidal effect Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229960000969 phenyl salicylate Drugs 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 208000034656 Contusions Diseases 0.000 description 3
- 208000010040 Sprains and Strains Diseases 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000008601 oleoresin Substances 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000001896 cresols Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- -1 stearic or palmitic Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Definitions
- This invention relates to medicated ointment compositions; and in particular it relates to novel compositions of this general class which are characterized by an effective content of a phenylphenol, especially ortho- 1y water-insoluble organic medicaments, of
- aqueous solutions of drugs or medicaments which are soluble in water can be mixed with lanoline or other appropriate ointment base, and that when the mixture is applied to the surface of the skin, the medication will be carried into the tissues on account of the ability of the associated water to diffuse.
- drugs or medicaments contained in ointments as heretofore compounded are insoluble or only difficultly soluble in water, there is usually little or no penetration of the tissues by such medicinal agents, irrespective of whether or not water is present in the mixture, and consequently substantially no remedial action beyond the immediate locus of administration.
- a principal object of the present invention is to improve the character of cerates, ointments, salves, and other mixtures of the general character above discussed, including liquid oleaginous preparations, all of which Application filed February 21, 1930. Serial No. 430,446.
- ointment compositions or mixtures may be generically termed ointment compositions or mixtures, in such manner that penetrative action of water-insoluble or difficultly water-soluble active agents contained in said ointment compositions is brought about or increased without causing irritation of the tissues, thus enhancing the healing, antiseptic, germicidal and/or other desired effects of said agents beyond what has been possible heretofore.
- Another object is to enable attainment of these results in a relatively simple manner and without unduly increasing the cost of such compositions.
- Other objects and advantages of the invention will appear as the description proceeds. It has been found that by admixing, with the usual ingredients of ointment compositions which are to include substantially or relatively water-insoluble medicaments.
- compositions are obtainable in which, even though no water has been used in compounding them, the active medicaments will penetrate the tissues when the compositions are applied locally in the usual manner, and will therefore be effective beyond the point of application.
- a phenylp'henol C H .C H OH
- orthophenylphenol a phenylp'henol
- compositions are obtainable in which, even though no water has been used in compounding them, the active medicaments will penetrate the tissues when the compositions are applied locally in the usual manner, and will therefore be effective beyond the point of application.
- the results thus attained are found to be especially pronounced and desirable in the case of organic medicaments, including those specifically named hereinabove as well as others to be mentioned presently.
- orthophenylphenol exhibit the peculiar and desirable property of conferring penetrative power upon arelatively Water-insoluble medicament when employed in accordance with the principles of the invention, but it does so without corrosive or other irritating action upon sensitive tissue, even tissue in an already inflamed condition. At the same time it is itself tissue-penetrative and a highly effective antiseptic and germicide also; and it is therefore valuable in a salve whether other medicaments are present or not. Besides being non-irritant and nondestructive of tissue, it is non-toxic in quantities even much exceeding those necessary or desirable to use in ointment compositions.
- the metaand para forms of phenylphenol save that they appear to possess much lower antiseptic and germicidal power, have desirable properties similar to those of orthophenylphenol as ointment composition ingredients and may be employed wholly or partly in lieu thereof where such lower antiseptic and germicidal power is not a deterrent. Ordinarily, however, it is desirable to use the orthocompound, or a mixture of the orthowith either the metaor the paracompound, or both, in which the orthocompound predominates.
- the orthocompound in particular is commercially available at moderate cost and imparts no disagreeable odor to the mixture, being itself practically odorless.
- the phenylphenols are markedly different from phenol (carbolic acid) or the cresols which are. both irritant and toxic in high degree.
- the bulk of the composition may consist of any suitable ointment base.
- the base may be an unguent, such as petrolatum, petroleum jelly, a fat such as lanolin or s uet, a fatty acid such as stearic or palmitic, a wax such as beeswax or paraffin wax, or mixtures of one or more of such substances with each other or with an oil capable of softening the unguent used, so that the resulting ointment composition is semi-solid or pasty in consistency.
- the ointment base may consist wholly or largely of a bland medicinal oil, such as white mineral oil, for example.
- the ointment composition usually contains one or more medicinal agents such as those mentioned hereinabove or others such as oleoresin capsicum, oleoresin ginger, and essential oils like mustard, sassafras, peppermint, rosemary, turpentine, and other therapeutic volatile oils of similar character, which may be used in treating colds, rheumatism, sprains and bruises.
- medicinal agents such as those mentioned hereinabove or others such as oleoresin capsicum, oleoresin ginger, and essential oils like mustard, sassafras, peppermint, rosemary, turpentine, and other therapeutic volatile oils of similar character, which may be used in treating colds, rheumatism, sprains and bruises.
- These medicaments while not in and of themselves tissue-penetrant, become so when mixed with phenylphenol, even in small amounts and largely dilutcd with a non-penetratingunguent, such as petrol
- phenylphenol Only a small amount of phenylphenol is required to give effective tissue-penetrating and germicidal properties. While the complete ointment composition may, without harmful results, contain 10% or more of phenylphenol, it is ordinarily suflicient to use smaller amounts, say around 3% to 5%. Even smaller amounts may be employed but ordinarily the amount used should not be much below 2%. Here, as elsewhere in the specification and claims, the stated proportions are by weight.
- phenylphenol above mentioned are not only sufficient to carry the medicaments of the ointment composition into the tissues effectively but are also sufficient, in the case of orthophenylphenol, to give the desired disinfecting action, even in the absence of other disinfecting substances.
- the ointment base constitutes over 50%, and more frequently between and 90%, of the complete ointment composition.
- the other medicaments commonly used in addition to the phenylphenol may be present in widely varying proportions relative to each other and to the phenylphenol. Ordinarily their aggregate amount exceeds that of the phenylphenol used and is usually considerably greater, being advantageously from two to six times the amount of the phenylphenol in typical formulae.
- ointment compositions compounded in accordance with the invention do not require inclusion of water as a constituent and are at least largely, and more often wholly, non-aqueous in character, this does not mean that water must be rigidly excluded in compounding themso long as they retain the characteristics of ointment compositions properly so termed.
- reference herein to a substance as substantially or relatively insoluble in water is not to be construed as necessarily signifying complete insolubility in a strict sense.
- the in vention relates more especially to enhancing the tissue-penetrating action of medicaments that are generally classifiable as comparatively insoluble in water
- the tissue-penetrating action of Water-soluble medicaments also may be increased by association with a phenyl-phenol in ointment compositions, and the invention in its broader aspects is to be understood as extending thereto.
- An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another medicinal agent.
- An ointment composition comprising an, ointment base, with which are compounded a phenylphenol and another organic medicinal agent.
- An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another substantially water-insoluble medicinal agent.
- An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another substantially water-insoluble organic medicinal agent.
- An ointment composition comprising a substantially non-aqueous ointment base. with which are compounded a plurality of relatively water-insoluble meclicaments, one of which is orthophenylphenol employed in minor proportion of the total quantity of said medicaments.
- An ointment composition comprising an oleaginous base,with which are compounded a therapeutic volatile oil and a phenylphenol.
- An ointment composition comprising an oleaginous base, with which are compounded a plurality of therapeutic volatile oils, including a terpenic oil, and orthophenylphenol.
- An ointment composition comprising an oleaginous base, with which are compounded salol, a therapeutic volatile oil, and orthophenylphenol.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Patented Aug. 2, E552 UNITED STATES HENRYI. FULLER, OF WASHINGTON, DISTRICT OF COLUMBIA MEDICATED OINTMIENT COMPOSITION No Drawing.
This invention relates to medicated ointment compositions; and in particular it relates to novel compositions of this general class which are characterized by an effective content of a phenylphenol, especially ortho- 1y water-insoluble organic medicaments, of
which one is a phenylphenol, compounded with a suitable ointment base which is of oleaginous nature and generally water-free or substantially so, the medication being tis-' sue-penetrative to a marked degree and therefore effective beyond the seat of application.
It is a well known fact that aqueous solutions of drugs or medicaments which are soluble in water can be mixed with lanoline or other appropriate ointment base, and that when the mixture is applied to the surface of the skin, the medication will be carried into the tissues on account of the ability of the associated water to diffuse. However, where drugs or medicaments contained in ointments as heretofore compounded are insoluble or only difficultly soluble in water, there is usually little or no penetration of the tissues by such medicinal agents, irrespective of whether or not water is present in the mixture, and consequently substantially no remedial action beyond the immediate locus of administration. This is particularly true of the great majority of ointments and salves made with petrolatum, fats, and/or waxes, containing camphor, menthol, eucalyptol, methyl salicylate, thymol, (all of which are grouped for pharmaceutical purposes under the head of volatile oils) salol, or the like, and other preparations of similar character, that are widely used for their reputed value in treating colds, rheumatism, sprains and bruises.
A principal object of the present invention is to improve the character of cerates, ointments, salves, and other mixtures of the general character above discussed, including liquid oleaginous preparations, all of which Application filed February 21, 1930. Serial No. 430,446.
may be generically termed ointment compositions or mixtures, in such manner that penetrative action of water-insoluble or difficultly water-soluble active agents contained in said ointment compositions is brought about or increased without causing irritation of the tissues, thus enhancing the healing, antiseptic, germicidal and/or other desired effects of said agents beyond what has been possible heretofore. Another object is to enable attainment of these results in a relatively simple manner and without unduly increasing the cost of such compositions. Other objects and advantages of the invention will appear as the description proceeds. It has been found that by admixing, with the usual ingredients of ointment compositions which are to include substantially or relatively water-insoluble medicaments. varying percentages of a phenylp'henol (C H .C H OH), particularly orthophenylphenol, compositions are obtainable in which, even though no water has been used in compounding them, the active medicaments will penetrate the tissues when the compositions are applied locally in the usual manner, and will therefore be effective beyond the point of application. The results thus attained are found to be especially pronounced and desirable in the case of organic medicaments, including those specifically named hereinabove as well as others to be mentioned presently. Not only does orthophenylphenol exhibit the peculiar and desirable property of conferring penetrative power upon arelatively Water-insoluble medicament when employed in accordance with the principles of the invention, but it does so without corrosive or other irritating action upon sensitive tissue, even tissue in an already inflamed condition. At the same time it is itself tissue-penetrative and a highly effective antiseptic and germicide also; and it is therefore valuable in a salve whether other medicaments are present or not. Besides being non-irritant and nondestructive of tissue, it is non-toxic in quantities even much exceeding those necessary or desirable to use in ointment compositions.
The metaand para forms of phenylphenol, save that they appear to possess much lower antiseptic and germicidal power, have desirable properties similar to those of orthophenylphenol as ointment composition ingredients and may be employed wholly or partly in lieu thereof where such lower antiseptic and germicidal power is not a deterrent. Ordinarily, however, it is desirable to use the orthocompound, or a mixture of the orthowith either the metaor the paracompound, or both, in which the orthocompound predominates. The orthocompound in particular is commercially available at moderate cost and imparts no disagreeable odor to the mixture, being itself practically odorless.
In their freedom not only from toxicity but also from irritating or corrosive action upon tissues, the phenylphenols are markedly different from phenol (carbolic acid) or the cresols which are. both irritant and toxic in high degree.
In an ointment composition embodying the principles of the invention, the bulk of the composition may consist of any suitable ointment base. In the case of a salve, the base may be an unguent, such as petrolatum, petroleum jelly, a fat such as lanolin or s uet, a fatty acid such as stearic or palmitic, a wax such as beeswax or paraffin wax, or mixtures of one or more of such substances with each other or with an oil capable of softening the unguent used, so that the resulting ointment composition is semi-solid or pasty in consistency. Where a. liquid ointment composition is desired, as in the case of an oil spray preparation for the nose and throat membranes, the ointment base may consist wholly or largely of a bland medicinal oil, such as white mineral oil, for example.
In addition to the base and the phenylphenol, the ointment composition usually contains one or more medicinal agents such as those mentioned hereinabove or others such as oleoresin capsicum, oleoresin ginger, and essential oils like mustard, sassafras, peppermint, rosemary, turpentine, and other therapeutic volatile oils of similar character, which may be used in treating colds, rheumatism, sprains and bruises. These medicaments, while not in and of themselves tissue-penetrant, become so when mixed with phenylphenol, even in small amounts and largely dilutcd with a non-penetratingunguent, such as petrolatum, or with a liquid oil base.
Only a small amount of phenylphenol is required to give effective tissue-penetrating and germicidal properties. While the complete ointment composition may, without harmful results, contain 10% or more of phenylphenol, it is ordinarily suflicient to use smaller amounts, say around 3% to 5%. Even smaller amounts may be employed but ordinarily the amount used should not be much below 2%. Here, as elsewhere in the specification and claims, the stated proportions are by weight.
The amounts of phenylphenol above mentioned are not only sufficient to carry the medicaments of the ointment composition into the tissues effectively but are also sufficient, in the case of orthophenylphenol, to give the desired disinfecting action, even in the absence of other disinfecting substances. Usually the ointment base constitutes over 50%, and more frequently between and 90%, of the complete ointment composition.
The other medicaments commonly used in addition to the phenylphenol, may be present in widely varying proportions relative to each other and to the phenylphenol. Ordinarily their aggregate amount exceeds that of the phenylphenol used and is usually considerably greater, being advantageously from two to six times the amount of the phenylphenol in typical formulae.
In preparing one desirable type of ointment composition embodying the principles of the invention, the following medicaments, including orthophenylphenol, are compounded together in the indicated proportions by weight:
Parts Camphor 3O Eucalyptol 20 Salol v l0 Methyl salicylaten 10 Orthophenylphenol 20 Menthol 5 Thymol 5 This yields a fluid mixture with which a suitable ointment base may be compounded. Thus, for example, if the desired ointment composition is to have a salve-like consistency at ordinary temperatures, 20 parts of the fluid mixture may be added to 80 parts of petrolatum, or to a mixture of 70 to parts of petrolatum with 5 to 10 parts of paraflin. When these ingredients are thoroughly compounded, there results a medicinal salve or ointment which is useful for a variety of purposes, such as treating head and chest colds, muscular aches and pains, sprains, bruises, etc. The medicaments in such an ointment, including especially terpenic volatile oils, and salol, are endowed with marked tissue-penetrating power due to the presence of the orthophe nylphenol; and this type of ointment is regarded as one of the most important and advantageous embodiments of the invention.
The foregoing specific example is to be understood not as restrictive, but as merely illustrative of one advantageous way of compounding ointment compositions in accordance with the broad underlying principles of the invention herein set forth and claimed.
While ointment compositions compounded in accordance with the invention do not require inclusion of water as a constituent and are at least largely, and more often wholly, non-aqueous in character, this does not mean that water must be rigidly excluded in compounding themso long as they retain the characteristics of ointment compositions properly so termed. Likewise reference herein to a substance as substantially or relatively insoluble in water is not to be construed as necessarily signifying complete insolubility in a strict sense. Although the in vention relates more especially to enhancing the tissue-penetrating action of medicaments that are generally classifiable as comparatively insoluble in water, the tissue-penetrating action of Water-soluble medicaments also may be increased by association with a phenyl-phenol in ointment compositions, and the invention in its broader aspects is to be understood as extending thereto.
What is claimed is:
1. An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another medicinal agent.
2. An ointment composition comprising an, ointment base, with which are compounded a phenylphenol and another organic medicinal agent.
3. An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another substantially water-insoluble medicinal agent.
4. An ointment composition comprising an ointment base, with which are compounded a phenylphenol and another substantially water-insoluble organic medicinal agent.
5. An ointment composition as defined in claim 1. wherein the phenylphenol is chiefly ortho henvlphenol.
6. An ointment composition as defined in claim 4, wherein the phenylphenol is chiefly orthophenvlphenol.
7. An ointment composition of salve-like consistency containing a phenylphenol, at least 50 per cent by weight of said composition being an unguent.
8. An ointment composition as defined in claim 7, containing from about2 to 10 per cent of orthophenylphenol.
9. An ointment composition comprising a substantially non-aqueous ointment base. with which are compounded a plurality of relatively water-insoluble meclicaments, one of which is orthophenylphenol employed in minor proportion of the total quantity of said medicaments.
10. An ointment composition comprising an oleaginous base,with which are compounded a therapeutic volatile oil and a phenylphenol.
11. An ointment composition comprising an oleaginous base, with which are compounded a plurality of therapeutic volatile oils, including a terpenic oil, and orthophenylphenol.
12. An ointment composition comprising an oleaginous base, with which are compounded salol, a therapeutic volatile oil, and orthophenylphenol.
13. An ointment composition comprising 'petrolatum with which are compounded cam- In testimony whereof I hereunto aflix my signature.
HENRY O. FULLER.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US430446A US1870107A (en) | 1930-02-21 | 1930-02-21 | Medicated ointment composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US430446A US1870107A (en) | 1930-02-21 | 1930-02-21 | Medicated ointment composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US1870107A true US1870107A (en) | 1932-08-02 |
Family
ID=23707592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US430446A Expired - Lifetime US1870107A (en) | 1930-02-21 | 1930-02-21 | Medicated ointment composition |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US1870107A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097229A (en) * | 1960-03-04 | 1963-07-09 | Monsanto Chemicals | Cycloaliphatic chlorocarbanilates |
| US3142646A (en) * | 1960-04-11 | 1964-07-28 | Monsanto Co | Antiseptic detergent formulations containing halogenated carbanilates |
| US3353970A (en) * | 1964-12-21 | 1967-11-21 | Scott Chemical And Welding Pro | Metal spatter-fouling inhibiting material and method |
| US4702916A (en) * | 1985-12-03 | 1987-10-27 | Warner-Lambert Company | Analgesic stick compositions |
| US20060073219A1 (en) * | 2004-10-04 | 2006-04-06 | Marc Selner | Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
-
1930
- 1930-02-21 US US430446A patent/US1870107A/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097229A (en) * | 1960-03-04 | 1963-07-09 | Monsanto Chemicals | Cycloaliphatic chlorocarbanilates |
| US3142646A (en) * | 1960-04-11 | 1964-07-28 | Monsanto Co | Antiseptic detergent formulations containing halogenated carbanilates |
| US3353970A (en) * | 1964-12-21 | 1967-11-21 | Scott Chemical And Welding Pro | Metal spatter-fouling inhibiting material and method |
| US4702916A (en) * | 1985-12-03 | 1987-10-27 | Warner-Lambert Company | Analgesic stick compositions |
| US20060073219A1 (en) * | 2004-10-04 | 2006-04-06 | Marc Selner | Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| US7597913B2 (en) * | 2004-10-04 | 2009-10-06 | Marc Selner | Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7858570B2 (en) | Compositions and methods for removing urushiol and treating the resulting skin condition | |
| JP6228540B2 (en) | Pain reducing composition comprising a TRPV1-selective agonist and its manufacture and use | |
| JP5694665B2 (en) | Topical preparation and its usage | |
| JP6563954B2 (en) | Topical composition, manufacture and use for pain relief | |
| JPS59108716A (en) | Antiacne composition | |
| US9775872B2 (en) | Topical pharmaceutical bases for preventing viral diseases | |
| BR112020019875A2 (en) | TOPICAL COMPOSITIONS FOR PAIN RELIEF | |
| JP2693859B2 (en) | Acne vulgaris skin external preparation for acne | |
| US5137718A (en) | Infection fighting composition for topical application | |
| US6126950A (en) | Composition useful for healing and protecting skin | |
| BRPI0715157A2 (en) | Treatment method and typical antiviral composition | |
| US7238680B2 (en) | Topical compositions for veterinary uses | |
| US20120225143A1 (en) | Cold sore formulation and related method of manufacture | |
| US1870107A (en) | Medicated ointment composition | |
| US3809749A (en) | Topical pharmaceutical composition and method employing sap from the tree croton lechleri | |
| US2576987A (en) | Fungicidal composition for treating the human skin | |
| RU2739295C1 (en) | Antiseptic | |
| JP3240553B2 (en) | Herbal cream and preparation for herbal cream | |
| JPS6333326A (en) | Antibacterial composition | |
| US321839A (en) | Stanley w | |
| RU2788332C1 (en) | Ointment for the treatment of traumatic damage to the skin | |
| KR102723936B1 (en) | Skin external composition comprising badger oil | |
| US9867775B2 (en) | Topical pharmaceutical bases for treating inflammatory disorders | |
| US2105197A (en) | Medicament | |
| US2281937A (en) | Therapeutic composition |